Erlotinib: as maintenance monotherapy in non-small-cell lung cancer
VJ Muir, S Dhillon - BioDrugs, 2011 - Springer
… [11] Recently, erlotinib monotherapy has been … oral erlotinib as monotherapy for maintenance
treatment in patients with NSCLC. Medical literature on the use of erlotinib as monotherapy …
treatment in patients with NSCLC. Medical literature on the use of erlotinib as monotherapy …
[HTML][HTML] Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer …
N Yamamoto, T Seto, M Nishio, K Goto, I Okamoto… - Lung Cancer, 2021 - Elsevier
… This report represents the first analysis of OS benefit with the combination of erlotinib
plus bevacizumab vs erlotinib monotherapy in EGFR+ NSCLC. The significant PFS benefit …
plus bevacizumab vs erlotinib monotherapy in EGFR+ NSCLC. The significant PFS benefit …
[HTML][HTML] Efficacy and safety of erlotinib monotherapy for Japanese patients with advanced non-small cell lung cancer: a phase II study
K Kubota, Y Nishiwaki, T Tamura, K Nakagawa… - Journal of Thoracic …, 2008 - Elsevier
… safety of Erlotinib in Japanese patients with previously treated non-small cell lung cancer
(… This report presents the results of the first phase II study of erlotinib conducted in Japanese …
(… This report presents the results of the first phase II study of erlotinib conducted in Japanese …
Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non–small cell lung cancer cells
T Li, YH Ling, ID Goldman, R Perez-Soler - Clinical cancer research, 2007 - AACR
… agent for this indication was docetaxel as monotherapy (1, 2). No … Pemetrexed and erlotinib
monotherapy have different … On this basis, both agents were approved as monotherapy …
monotherapy have different … On this basis, both agents were approved as monotherapy …
Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
S Ricciardi, S Tomao, F de Marinis - Lung Cancer: Targets and …, 2010 - Taylor & Francis
… Erlotinib monotherapy is indicated for the treatment of … Erlotinib monotherapy has shown a
significant improvement … Most commonly reported erlotinib-related adverse effects were rash …
significant improvement … Most commonly reported erlotinib-related adverse effects were rash …
Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology …
R Dickson, A Bagust, A Boland, M Blundell, H Davis… - …, 2011 - Springer
… This article presents a summary of the ERG report for the STA of erlotinib as monotherapy
for the maintenance treatment of patients with non-small cell lung cancer (NSCLC) and stable …
for the maintenance treatment of patients with non-small cell lung cancer (NSCLC) and stable …
[HTML][HTML] … of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active EGFR mutations: Okayama Lung Cancer …
H Yoshioka, K Hotta, K Kiura, N Takigawa… - Journal of Thoracic …, 2010 - Elsevier
… The analysis showed that hazard ratios of erlotinib therapy … This indicates that erlotinib therapy
might be also beneficial … a phase II trial of erlotinib monotherapy in Japanese patients with …
might be also beneficial … a phase II trial of erlotinib monotherapy in Japanese patients with …
[HTML][HTML] Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group
JE Uhm, BB Park, MJ Ahn, J Lee, JS Ahn… - Journal of Thoracic …, 2009 - Elsevier
… rate was observed with erlotinib monotherapy in NSCLC patients… In conclusion, this study
indicates that erlotinib monotherapy … Tumor responses and survival outcomes for erlotinib were …
indicates that erlotinib monotherapy … Tumor responses and survival outcomes for erlotinib were …
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an …
H Saito, T Fukuhara, N Furuya, K Watanabe… - The Lancet …, 2019 - thelancet.com
… the combination of bevacizumab and erlotinib was compared with erlotinib monotherapy to
evaluate activity in patients with non-small-cell lung cancer (NSCLC) who were not stratified …
evaluate activity in patients with non-small-cell lung cancer (NSCLC) who were not stratified …
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models
B Higgins, K Kolinsky, M Smith, G Beck… - Anti-cancer …, 2004 - journals.lww.com
… Our objective was the preclinical assessment of the pharmacokinetics, monotherapy and …
kinase inhibitor erlotinib in athymic nude mice bearing non-small cell lung cancer (NSCLC) …
kinase inhibitor erlotinib in athymic nude mice bearing non-small cell lung cancer (NSCLC) …
相关搜索
- non-small cell lung cancer
- erlotinib in patients cell lung cancer
- maintenance treatment cell lung cancer
- first line treatment cell lung cancer
- trust study cell lung cancer
- maintenance therapy cell lung cancer
- small cell lung cancer erlotinib alone
- erlotinib sensitivity cell lung cancer
- previously treated patients cell lung cancer
- small cell lung cancer select subsets
- phase ii study cell lung cancer
- efficacy and safety cell lung cancer
- systematic review cell lung cancer
- randomized trials cell lung cancer
- pooled analysis cell lung cancer
- trial of erlotinib cell lung cancer